Your browser doesn't support javascript.
loading
Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys.
Wang, Shuang; Peng, Yun; Wang, Rongjuan; Jiao, Shasha; Wang, Min; Huang, Weijin; Shan, Chao; Jiang, Wen; Li, Zepeng; Gu, Chunying; Chen, Ben; Hu, Xue; Yao, Yanfeng; Min, Juan; Zhang, Huajun; Chen, Ying; Gao, Ge; Tang, Peipei; Li, Gang; Wang, An; Wang, Lan; Zhang, Jinchao; Chen, Shuo; Gui, Xun; Yuan, Zhiming; Liu, Datao.
Afiliação
  • Wang S; Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China.
  • Peng Y; Beijing Kohnoor Science & Technology Co., Ltd, 102206, Beijing, China.
  • Wang R; Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, 430071, Wuhan, Hubei, China.
  • Jiao S; Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China.
  • Wang M; Beijing Kohnoor Science & Technology Co., Ltd, 102206, Beijing, China.
  • Huang W; Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China.
  • Shan C; Beijing Kohnoor Science & Technology Co., Ltd, 102206, Beijing, China.
  • Jiang W; Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China.
  • Li Z; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, 100050, Beijing, China.
  • Gu C; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, 430071, Wuhan, Hubei, China.
  • Chen B; Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China.
  • Hu X; Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China.
  • Yao Y; Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China.
  • Min J; Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China.
  • Zhang H; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, 430071, Wuhan, Hubei, China.
  • Chen Y; Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, 430071, Wuhan, Hubei, China.
  • Gao G; Wuhan Institute of Virology, Chinese Academy of Sciences, 430071, Wuhan, Hubei, China.
  • Tang P; Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, 430071, Wuhan, Hubei, China.
  • Li G; Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, 430071, Wuhan, Hubei, China.
  • Wang A; Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, 430071, Wuhan, Hubei, China.
  • Wang L; Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China.
  • Zhang J; Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China.
  • Chen S; Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China.
  • Gui X; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, 100050, Beijing, China.
  • Yuan Z; Mabwell (Shanghai) Bioscience Co., Ltd, 201210, Shanghai, China.
  • Liu D; Ludwig Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK. ericshuochen@gmail.com.
Nat Commun ; 11(1): 5752, 2020 11 13.
Article em En | MEDLINE | ID: mdl-33188207
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Pneumonia Viral / Infecções por Coronavirus / Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / Betacoronavirus / Anticorpos Monoclonais Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Pneumonia Viral / Infecções por Coronavirus / Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / Betacoronavirus / Anticorpos Monoclonais Idioma: En Ano de publicação: 2020 Tipo de documento: Article